Clinical trial
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
NCT03045029 is registered in ClinicalTrials.gov with United Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ADAPT - A Patient Registry of the Real-world Use of Orenitram®
- Lead sponsor
- United Therapeutics
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- July 18, 2017
- Completion date
- March 31, 2027
- Enrollment
- 300 (estimated)
- Sites
- 41
Conditions
As the registry lists them; a condition with its own page is linked.